Synthetic red blood cell-specific glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG) inhibits Plasmodium falciparum development in vitro

Detalhes bibliográficos
Autor(a) principal: Morais, Inês
Data de Publicação: 2022
Outros Autores: Medeiros, Márcia M., Carvalho, Maria, Morello, Judit, Teixeira, Sara M., Maciel, Suelma, Nhantumbo, Janice, Balau, Ana, Rosa, Margarida T. G., Nogueira, Fátima, Rodrigues, João Alexandre, Carvalho, Filomena Almeida, Antunes, Alexandra M. M., Arez, Ana Paula
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/52234
Resumo: Copyright © 2022 Morais, Medeiros, Carvalho, Morello, Teixeira, Maciel, Nhantumbo, Balau, Rosa, Nogueira, Rodrigues, Carvalho, Antunes and Arez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
id RCAP_db7b5fdeb9cb73cc4c37131604867a67
oai_identifier_str oai:repositorio.ul.pt:10451/52234
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Synthetic red blood cell-specific glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG) inhibits Plasmodium falciparum development in vitro2,3-BPG2,3-DPGGlycolysisHost–parasite interactionsMalariaPyruvate kinase deficiencyRed blood cellCopyright © 2022 Morais, Medeiros, Carvalho, Morello, Teixeira, Maciel, Nhantumbo, Balau, Rosa, Nogueira, Rodrigues, Carvalho, Antunes and Arez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Mechanisms of malaria parasite interaction with its host red blood cell may provide potential targets for new antimalarial approaches. Pyruvate kinase deficiency has been associated with resistance to malaria in both experimental models and population studies. Two of the major pyruvate kinase deficient-cell disorders are the decrease in ATP and the increase in 2,3-biphosphoglycerate (2,3-BPG) concentration. High levels of this metabolite, only present in mammalian red blood cell, has an inhibitory effect on glycolysis and we hypothesized that its accumulation may also be harmful to the parasite and be involved in the mechanism of protection provided by that enzymopathy. We examined the effect of a synthetic form, 2,3-DPG, on the Plasmodium falciparum intraerythrocytic developmental cycle in vitro. Results showed an impairment of parasite growth with a direct effect on parasite maturation as significant lower progeny emerged from parasites that were submitted to 2,3-DPG. Further, adding the compound to the culture medium did not result in any effect on the host cell, but instead the metabolic profile of an infected cell became closer to that of a non-infected cell.This research was funded by Fundação para a Ciência e Tecnologia (https://www.fct.pt/index.phtml.en), projects PTDC_BIA-CEL_28456_2017 and GHTM - UID/04413/2020 (https://ghtm.ihmt.unl.pt/).FrontiersRepositório da Universidade de LisboaMorais, InêsMedeiros, Márcia M.Carvalho, MariaMorello, JuditTeixeira, Sara M.Maciel, SuelmaNhantumbo, JaniceBalau, AnaRosa, Margarida T. G.Nogueira, FátimaRodrigues, João AlexandreCarvalho, Filomena AlmeidaAntunes, Alexandra M. M.Arez, Ana Paula2022-04-06T16:23:08Z20222022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/52234engFront Cell Infect Microbiol. 2022 Mar 15;12:84096810.3389/fcimb.2022.8409682235-2988info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:57:21Zoai:repositorio.ul.pt:10451/52234Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:03:23.463733Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Synthetic red blood cell-specific glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG) inhibits Plasmodium falciparum development in vitro
title Synthetic red blood cell-specific glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG) inhibits Plasmodium falciparum development in vitro
spellingShingle Synthetic red blood cell-specific glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG) inhibits Plasmodium falciparum development in vitro
Morais, Inês
2,3-BPG
2,3-DPG
Glycolysis
Host–parasite interactions
Malaria
Pyruvate kinase deficiency
Red blood cell
title_short Synthetic red blood cell-specific glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG) inhibits Plasmodium falciparum development in vitro
title_full Synthetic red blood cell-specific glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG) inhibits Plasmodium falciparum development in vitro
title_fullStr Synthetic red blood cell-specific glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG) inhibits Plasmodium falciparum development in vitro
title_full_unstemmed Synthetic red blood cell-specific glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG) inhibits Plasmodium falciparum development in vitro
title_sort Synthetic red blood cell-specific glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG) inhibits Plasmodium falciparum development in vitro
author Morais, Inês
author_facet Morais, Inês
Medeiros, Márcia M.
Carvalho, Maria
Morello, Judit
Teixeira, Sara M.
Maciel, Suelma
Nhantumbo, Janice
Balau, Ana
Rosa, Margarida T. G.
Nogueira, Fátima
Rodrigues, João Alexandre
Carvalho, Filomena Almeida
Antunes, Alexandra M. M.
Arez, Ana Paula
author_role author
author2 Medeiros, Márcia M.
Carvalho, Maria
Morello, Judit
Teixeira, Sara M.
Maciel, Suelma
Nhantumbo, Janice
Balau, Ana
Rosa, Margarida T. G.
Nogueira, Fátima
Rodrigues, João Alexandre
Carvalho, Filomena Almeida
Antunes, Alexandra M. M.
Arez, Ana Paula
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Morais, Inês
Medeiros, Márcia M.
Carvalho, Maria
Morello, Judit
Teixeira, Sara M.
Maciel, Suelma
Nhantumbo, Janice
Balau, Ana
Rosa, Margarida T. G.
Nogueira, Fátima
Rodrigues, João Alexandre
Carvalho, Filomena Almeida
Antunes, Alexandra M. M.
Arez, Ana Paula
dc.subject.por.fl_str_mv 2,3-BPG
2,3-DPG
Glycolysis
Host–parasite interactions
Malaria
Pyruvate kinase deficiency
Red blood cell
topic 2,3-BPG
2,3-DPG
Glycolysis
Host–parasite interactions
Malaria
Pyruvate kinase deficiency
Red blood cell
description Copyright © 2022 Morais, Medeiros, Carvalho, Morello, Teixeira, Maciel, Nhantumbo, Balau, Rosa, Nogueira, Rodrigues, Carvalho, Antunes and Arez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
publishDate 2022
dc.date.none.fl_str_mv 2022-04-06T16:23:08Z
2022
2022-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/52234
url http://hdl.handle.net/10451/52234
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Front Cell Infect Microbiol. 2022 Mar 15;12:840968
10.3389/fcimb.2022.840968
2235-2988
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers
publisher.none.fl_str_mv Frontiers
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134584439308288